City Research Online

Items where Author is "Finger, R. P."

Up a level
Group by: Type | No Grouping
Number of items: 17.

Article

Dunbar, H. M. P. ORCID: 0000-0002-7149-5122, Crabb, D. P., Behning, C. ORCID: 0000-0002-9310-3804 (2025). Heterogeneous Visual Function Deficits in Intermediate Age-Related Macular Degeneration: A MACUSTAR Report. Ophthalmology Science, 5(4), article number 100708. doi: 10.1016/j.xops.2025.100708

Terheyden, J. H., Holz, F. G., Behning, C. (2025). The Spectrum of Functional, Structural and Patient-Reported Outcomes in Intermediate Age-Related Macular Degeneration – A MACUSTAR Study Report. Ophthalmologica, 248(2), pp. 101-111. doi: 10.1159/000543231

Terheyden, J. H., Dunbar, H. M. P., Schmitz-Valckenberg, S. (2025). Validating candidate endpoints for intermediate age-related macular degeneration trials in a multi-centre setting—lessons from the MACUSTAR study. Eye, 39(6), pp. 1031-1039. doi: 10.1038/s41433-024-03568-2

Terheyden, J. H., Gittel, L., Jungblut, J. (2024). Heterogeneity of patient-reported outcome measures in clinical research. Health and Quality of Life Outcomes, 22(1), article number 65. doi: 10.1186/s12955-024-02282-7

Rowen, D., Carlton, J., Terheyden, J. H. (2024). Development and Valuation of a Preference-Weighted Measure in Age-Related Macular Degeneration From the Vision Impairment in Low Luminance Questionnaire—A MACUSTAR Report. Value in Health, 27(5), pp. 642-654. doi: 10.1016/j.jval.2024.02.001

von der Emde, L., Mallwitz, M., Vaisband, M. (2023). Retest variability and patient reliability indices of quantitative fundus autofluorescence in age-related macular degeneration: a MACUSTAR study report. Scientific Reports, 13(1), article number 17417. doi: 10.1038/s41598-023-43417-y

Higgins, B. E. ORCID: 0000-0002-4530-6156, Montesano, G. ORCID: 0000-0002-9148-2804, Dunbar, H. M. P. (2023). Test-Retest Variability and Discriminatory Power of Measurements From Microperimetry and Dark Adaptation Assessment in People With Intermediate Age-Related Macular Degeneration - A MACUSTAR Study Report.. Translational Vision Science & Technology, 12(7), article number 19. doi: 10.1167/tvst.12.7.19

Saßmannshausen, M., Behning, C., Weinz, J. (2023). Characteristics and Spatial Distribution of Structural Features in Age-Related Macular Degeneration: A MACUSTAR Study Report. Ophthalmology Retina, 7(5), pp. 420-430. doi: 10.1016/j.oret.2022.12.007

Saßmannshausen, M., Behning, C., Isselmann, B. (2022). Relative ellipsoid zone reflectivity and its association with disease severity in age-related macular degeneration: a MACUSTAR study report. Scientific Reports, 12(1), article number 14933. doi: 10.1038/s41598-022-18875-5

Dunbar, H. M. P., Behning, C., Abdirahman, A. (2022). Repeatability and Discriminatory Power of Chart-Based Visual Function Tests in Individuals With Age-Related Macular Degeneration: A MACUSTAR Study Report. JAMA Ophthalmology, 140(8), doi: 10.1001/jamaophthalmol.2022.2113

Ramke, J., Evans, J. R., Habtamu, E. (2022). Grand Challenges in global eye health: a global prioritisation process using Delphi method. The Lancet Healthy Longevity, 3(1), e31-e41. doi: 10.1016/s2666-7568(21)00302-0

Terheyden, J. H., Behning, C., Lüning, A. (2021). Challenges, facilitators and barriers to screening study participants in early disease stages-experience from the MACUSTAR study. BMC Medical Research Methodology, 21(1), article number 54. doi: 10.1186/s12874-021-01243-8

Terheyden, J. H., Ometto, G., Montesano, G. (2021). Automated quantification of posterior vitreous inflammation: optical coherence tomography scan number requirements. Scientific Reports, 11(1), article number 3271. doi: 10.1038/s41598-021-82786-0

Terheyden, J. H., Schmitz-Valckenberg, S., Crabb, D. P. ORCID: 0000-0001-8754-3902 (2020). Use of composite endpoints in early and intermediate age-related macular degeneration clinical trials - state-of-the-art and future directions. Ophthalmologica, 244(5), pp. 387-395. doi: 10.1159/000513591

Terheyden, J. H., Holz, F. G., Schmitz-Valckenberg, S. (2020). Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTAR.. Trials, 21(1), article number 659. doi: 10.1186/s13063-020-04595-6

Finger, R. P., Schmitz-Valckenberg, S., Schmidt, M. (2018). MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration. Ophthalmologica, 241(2), pp. 61-72. doi: 10.1159/000491402

Conference or Workshop Item

Dunbar, H. M. P., Sassmannshausen, M., Behning, C. (2022). Comparison of visual function in structurally defined sub-phenotypes of intermediate AMD: A MACUSTAR study report. In: Investigative Ophthalmology & Visual Science. ARVO Annual Meeting 2022, 1-4 May 2022, Denver, USA.

This list was generated on Sat May 3 05:13:19 2025 UTC.